Psychopharmacology of Multiple Sclerosis and Other Neurological Disorders

Baclofen is a centrally acting muscle relaxant that is commonly used to treat spasticity in multiple sclerosis.

Gabapentin and pregabalin primarily act by inhibiting voltage-gated calcium channels, reducing the release of excitatory neurotransmitters and thereby alleviating neuropathic pain.

SSRIs are commonly used to treat depression in multiple sclerosis due to their efficacy and generally favorable side effect profile.

Amantadine primarily acts by inhibiting dopamine reuptake, increasing the availability of dopamine in the synaptic cleft and thereby improving motor function in Parkinson's disease.

Acetylcholinesterase inhibitors, such as donepezil and rivastigmine, are commonly used to treat Alzheimer's disease by increasing the levels of acetylcholine in the brain.

Levetiracetam primarily acts by inhibiting voltage-gated sodium channels, reducing neuronal excitability and thereby preventing seizures.

Triptans, such as sumatriptan and zolmitriptan, are commonly used to treat migraine headaches due to their specific action on serotonin receptors in the brain.

Haloperidol is a typical antipsychotic that is commonly used to treat Tourette syndrome due to its efficacy in reducing tics.

Topiramate primarily acts by inhibiting voltage-gated sodium channels, reducing neuronal excitability and thereby preventing seizures.

Levodopa is a dopamine precursor that is commonly used to treat Parkinson's disease by increasing the levels of dopamine in the brain.